identified (SORT-E) (Supplementary
). We have demonstrated SORT in Escherichia coli, cultured mammalian cells, and Drosophila melanogaster 5, 6 , but not in any live vertebrate.
The CypK used for SORT in cultured cells and flies is prohibitively expensive for large animal experiments. We set out to develop SORT with Ne-(propargyloxycarbonyl)-l-lysine, AlkK (1, see Supplementary  Fig. 2 for chemical structures), a substrate for PylRS 7 that is 50 times cheaper than CypK to synthesize, metabolically stable in the mouse, and can be made available in the mouse brain through drinking water 8 . We optimized selective labeling of an AlkK-tagged E. coli proteome with an Azide-AlexaFluor 647 conjugate (Az-AF647) (Supplementary Fig. 3 ).
We constructed adeno-associated virus (AAV) vectors in which an mCherry-P2A-MmPylS genetic fusion is expressed from the neuron-specific, human synapsin 1 (hSyn1) promoter 9 , and PylT CAU (encoding Pyrrolysyl-tRNA CAU ) is expressed from the U6 promoter ( Supplementary Fig. 4 ) 8 . We transduced primary dissociated rat neocortex, containing neurons and glia, with our hSyn1 mCherry-P2A-MmPylS/PylT CAU (hSyn1-SORT CAU ) AAV in the presence of AlkK (Fig. 1a) . Following transduction, mCherry was clearly visible in neurons (NeuN-positive cells) but not in GFAP-positive glia (Fig. 1b) . We observed selective fluorescent labeling of this co-culture with Az-AF647 that was dependent on AlkK; labeling co-localized with both NeuN and mCherry, but not GFAP (Fig. 1b) . Moreover, a lysate from the co-culture receiving AlkK was selectively labeled with Az-AF647 ( Supplementary  Fig. 5 ).
We transduced slices of the mouse suprachiasmatic nucleus (SCN) 8 with the hSyn-SORT CAU AAV, added AlkK, and confirmed subsequent AAV-dependent mCherry expression (Fig. 1c) . We selectively labeled tagged proteins with Az-AF647 ( Fig. 1d and Supplementary Fig. 6 for all full gels). We demonstrated that SORT can be extended to tagging proteomes in a set of glial cells (astrocytes and ependymal cells 10, 11 ) by creating a GFAP mCherry-P2A-MmPylS/PylT CAU (GFAP-SORT CAU ) AAV (Fig. 1c,d and Supplementary Fig. 4 ). GFAP-driven SORT led to the expected mCherry expression pattern in the SCN 12 (Fig. 1c) , and the GFAP-positive proteome was labeled at a comparable level to the neuronal proteome (Fig. 1d) . Circadian oscillations can be followed in SCN slices derived from Period2::Luciferase (Per2::LUC) mice by bioluminescence, and these oscillations are known to be sensitive to cellular, electrical, and signaling perturbations of the SCN network 8 . We found that Per2::LUC organotypic SCN slices (slices that maintain their function in culture) that were transduced with hSyn I-SORT CAU or GFAP-SORT CAU AAVs and supplemented with AlkK retained robust circadian rhythms (Fig. 1e) .
Unilateral stereotactic injections of the hSyn1-SORT CAU AAV into the corpus striatum of the right hemisphere of adult mice were followed 1 week later by addition of AlkK to the drinking water. Coronal sections from the brains of mice after 1 week on AlkK revealed asymmetric mCherry fluorescence, primarily localized to the right hemisphere ( Fig. 2a and Supplementary Fig. 7a ). mCherry fluorescence Labeling and identifying celltype-specific proteomes in the mouse brain 1 We develop an approach to tag proteomes synthesized by specific cell types in dissociated cortex, brain slices, and the brains of live mice. By viral-mediated expression of an orthogonal pyrrolysyl-tRNA synthetase-tRNA XXX pair in a cell type of interest and providing a non-canonical amino acid with a chemical handle, we selectively label neuronal or glial proteomes. The method enables the identification of proteins from spatially and genetically defined regions of the brain.
Determining the proteomes of specific cells is a particular challenge in the mammalian central nervous system (CNS), where cell types form a network with dense chemical, electrical, and physical connectivity 1,2 . Efforts to elucidate proteomes of specific cell types in the CNS have used i) primary cell cultures or ii) cells that are acutely separated from tissue, by ex vivo manipulations, and purified on the basis of cell surface markers, for analysis 3 . However, the resulting cells are no longer in their physiological network, and may lose cellular structures (and their associated proteins), as well as chemical, electrical, and physical connectivity 3, 4 . Thus, isolated and cultured cells are likely to have adapted proteomes; the proteomes of cultured cells and acutely isolated cells are clearly different from each other 3 , and it is unclear how these proteomes relate to the proteome in vivo.
We previously reported stochastic orthogonal recoding of translation (SORT) for cell-type-specific tagging of proteomes, to enable labeling and identification of proteins from targeted cells without dissection 5, 6 . In SORT, an orthogonal pyrrolysyl-tRNA synthetase-tRNA XXX pair (where xxx indicates an anticodon sequence, and the pair is derived from Methanosarcina species, most commonly M. Mazei or M. barkeri) is expressed in the cell of interest. This pair recognizes an added noncanonical amino acid (ncAA) substrate containing a bioorthogonal cyclopropene group (CypK), and decodes a specific sense codon in competition with an endogenous aminoacyl-tRNA synthetase-tRNA XXX pair, leading to stochastic and low level tagging of the proteome with CypK. The tagged proteome can be labeled (SORT-M) or enriched and positive cells (Supplementary Fig. 10 ), and demonstrating that the approach can be used in different regions of the brain.
Numerous mouse strains have been created in which Cre recombinase is expressed in targeted cell types in the mouse brain 13 . We generated the hSyn1-FLEX-SORT CAU AAV ( Supplementary Fig. 4) , which facilitates the irreversible Cre-mediated flipping of an inverted mCherry-P2A-MmPylS gene cassette, for expression from the upstream promoter 14, 15 . We observed SORT tagging when we injected the hSyn1-FLEX-SORT-CAU AAV into the left striatum of Vgat-Cre mice (expressing Cre in inhibitory GABAergic neurons) (Fig. 2d) , but not in mice lacking Cre recombinase. We also injected the hSyn1-FLEX-SORT CAU AAV into the hippocampus of the right hemisphere in Vgat-Cre mice and Vglut-Cre mice (expressing Cre subset of excitatory neurons) and observed proteome tagging in both cases (Fig. 2e-j and Supplementary Fig. 7d,e) .
Next we tagged the proteome of neurons in the striatum, expecting to primarily tag proteins from medium spiny neurons (MSNs) involved in the post-synaptic side of dopaminergic synapses and glutamatergic synapses, and both the pre-synaptic and post-synaptic side of GABAergic synapses, as well as, potentially, interneurons 16 ( Supplementary  Fig. 11 ). We developed a SORT-E protocol for AlkK-tagged proteomes co-localized with NeuN but not with GFAP (Fig. 2b) . We labeled protein extracts from the striatum of each hemisphere with Az-AF647 and observed selective labeling of the proteome from the right hemisphere (Fig. 2c) . The efficiency of SORT tagging in mice was comparable to that in E. coli (Supplementary Fig. 8) .
We compared the total striatal proteome of control mice and mice subject to SORT tagging in both hemispheres (Supplementary Fig. 9 ). We found a strong correlation (Pearson correlation coefficient = 0.98) between the proteomes, comparable to the correlation between independent SORT proteomes (0.98) or the correlation between independent control proteomes (0.98). Similarly, we found an excellent correlation (0.98) between the proteomes of mice fed AlkK or injected with the hSyn1-SORT CAU AAV and the control proteome. The mice subject to SORT were healthy and maintained their body weight throughout the study (Supplementary Fig. 9 ).
We also carried out unilateral stereotactic injections of the hSyn1-SORT CAU or GFAP-SORT CAU AAV into the hippocampus in the right hemisphere of adult mice (Supplementary Fig. 7b,c) . We observed selective labeling of the proteome from the right hemisphere of the hippocampus via SORT-M, co-localizing either with neurons or GFAP- ( Supplementary Fig. 12 ). We prepared lysates from the striatum of brains of mice bilaterally injected with the hSyn1-SORT CAU AAV and provided with AlkK, covalently labeled the resulting proteome with an azide-diazobenzene-biotin conjugate (2) 17, 18 (Supplementary Fig. 2 ), captured the proteome on streptavidin beads, washed extensively, and then cleaved the diazobenzene linker to provide a SORT-E output (Supplementary Fig. 1 ). We observed clear enrichment of the SORT-E output with respect to non-tagged control outputs (Fig. 2k) .
By tandem mass spectrometry (MS/MS) analysis we assessed the relative abundance of each protein in the SORT-E output to its abundance in the control output ( Fig. 2l and Supplementary Data 1) . For 96% of the 2,119 proteins captured, this ratio is >1, demonstrating the specificity of the enrichment protocol for SORT-tagged proteins. We identified 1,789 proteins, defined as SORT-E IDs, that are enriched in the SORTtagged proteome compared to the control (1,604 proteins, significance curve S 0 = 1, false-discovery rate (FDR) < 0.05), or are found in three The P values for neuron part are from GO analysis. Each Log 2 (SORT-E output/control output) data point is calculated in Perseus using n = 3 SORT-E output measurements and n = 6 control output measurements. (m) The y axis is the Log 2 ratio of the label-free quantification value. The data show the mean of three independent replicates, ± s.e.m. *P < 0.05, **P < 0.005 for a ratio < 0. Statistics were calculated with a one-sample t-test (H 0 :µ = 0) and the significance of the two-tailed test was reported. (n) Euler diagram indicates the partitioning of glial-specific proteins in cultured glia between SORT-E-enriched and de-enriched. (o) As for n, but using glial-specific proteins from acutely isolated glia. Information on statistics and reproducibility for all panels are provided in the Online Methods.
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independent replicates of the SORT-tagged proteome, but only zero or one time in six independent controls (185 proteins) (Supplementary Data 1). In contrast we found only 24 proteins that are enriched in the control proteome (7 proteins, S 0 = 1, FDR < 0.05), or are only found in the control proteome (17 proteins). The SORT-E IDs define a set of proteins from the genetically targeted striatal neurons (Fig. 2l) .
Established neuronal markers are enriched in the SORT-E output, as are canonical markers of MSNs (Fig. 2l and Supplementary Table 1) . Neuronal proteins were significantly enriched in SORT-E IDs (P(neuron part) = 2.8 × 10 -7 ), but not in SORT-E NS (P(neuron part) = 0.17), with respect to the total striatal proteome (Fig. 2l) . SORT-E IDs include several markers of GABAergic synapses, as well as established markers of the post-synaptic side of glutamatergic synapses and dopaminergic synapses (Supplementary Table 1 and Supplementary Fig. 13 ).
The majority of glial markers are not enriched in the SORT-E output, consistent with the low expression of many glial markers in neurons (Fig. 2l) , and most glial markers are de-enriched by SORT-E with respect to the striatal proteome (Fig. 2m) . We found that proteins identified as glia-specific, in glia isolated from mouse brains, but not those identified as glia-specific, from cultured glia 3 , are significantly de-enriched by SORT-E (P = 3.38 × 10 -5 and P = 0.17, respectively) ( Fig. 2n,o) .
We have demonstrated a modular approach to co-translational proteome tagging in specific cells in primary culture, in mouse organotypic tissues slices and in the brains of live mice. Our approach complements a very recently described approach for cell-specific proteome tagging 19 . Because our SORT approach uses viral injection in combination with specific promoters it provides independent spatial and genetic control of proteome tagging. Extensions of SORT may introduce additional chemistries into the mouse proteome 20 , including photo-crosslinkers to interrogate cell-type-specific protein interactions, and may be extended to additional codons to provide greater proteome coverage 5 .
Methods
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
B R I E F C O M M U N I C AT I O N S
and GlutaMAX (ThermoFisher) at 37 °C under 5% CO 2 atmosphere. The cells were initially seeded in the presence of 2.5% FBS, switched to serum-free media after 24 h. Subsequently, half of the media was exchanged every 5 d.
SORT in dissociated rat cortical neurons and glial cells. Dissociated cultures were transduced after culturing for 3 d by addition of 1-2 µL (~10 12 -10 13 transducing units) of pSynI-mCherry::P2A::MmPylS/PylT CAU AAV particles into a single well of 6-well plates or 8-well coverslips, and the media was supplemented with 1 mM AlkK 1 at this time. Half of the media was exchanged every 5 d with or without the corresponding amino acid. The cells were analyzed 14 d after transduction. For lysate analysis, cells were washed with HBSS and incubated for 30 min on ice in RIPA buffer (10 mM Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA; 0.1% SDS; 1% Triton X-100; 1% deoxycholate), supplemented with protease inhibitor cocktail (Roche). The lysates were centrifuged for 10 min at 20,000g (4 °C), and the supernatant collected for analysis. For labeling and immunofluorescence, the cells were washed once with HBSS (ThermoFisher) and fixed with 4% (v/v) paraformaldehyde in HBSS. SORT-M in SCN slices. SCN organotypic slices were prepared from 7-to 9-day old C57/BL6 or Per2::LUC pups as reported previously 8 . Slices were transduced with 1 µL (~10 12 -10 13 transducing units) of hSyn1-mCherry::P2A::MmPylS/ PylT CAU AAV particles. After 2 weeks slices were transferred to culture media with 15 mM AlkK 2. The slices were imaged after 1 week of SORT labeling on a Leica DM IL LED inverted fluorescent microscope with QCapture Suite PLUS software. After imaging, the SCN slices were subsequently lysed by sonication in 8 M urea (PBS, pH 7.8) for subsequent fluorescent labeling of AlkK-containing proteins. Protein concentrations were determined by BCA assay (Pierce).
Labeling of fixed cells, immunofluorescence and confocal imaging.
Bioluminescence recordings of Per2::LUC SCN slices. Seven days after dissection of Per2::LUC SCN slices from the same litter, the slices were transduced with hSyn1-mCherry::P2A::MmPylS/PylT CAU or the corresponding GFAP AAV, transferred to a medum with 1 mM luciferin and placed into photo-multiplier tubes to record circadian oscillation as a bioluminescence signal as previously described 8 . After 2 weeks the medium was supplemented with 15 mM AlkK 1 and the bioluminescence signal was recorded for the successive 7 d during SORT protein labeling.
SORT in live mice. Adult male or female C57/BL6J, Vgat-Cre (JAX 016962) and Vglut-Cre (JAX 016963) mice aged 10 weeks, weighing 18-26 g were housed in cages on a 12 h light/dark cycle with ad libitum access to food and water. No randomization or blinding was used. The only exclusion criteria for animals were health issues. For viral injections, animals were anesthetized with 2% isofluorane and placed in a stereotaxic frame (David Kopf Instruments, Tujunga, CA). The mice received either unilateral or bilateral stereotactic injections of 2 ml of AAV1.hSyn1-mCherry::P2A::MmPylS/PylT CAU , AAV5.GFAP-mCherry::P2A::MmPylS/PylT CAU , or AAV1. hSyn1-FLEXmCherry::P2A::MmPylS/PylT CAU particles (2.0 µL of ~5 × 10 12 GC/mL; ~1 × 10 10 viral particles) into the region of the striatum (-1.7 mm medio-lateral, +0.7 mm anterior, -3.6 mm dorsal relative to bregma) or the dorsal hippocampus (-2.0 mm medio-lateral, -2.55 mm anterior, -2.0 mm dorsal relative to bregma). Injections were performed using a 5 ml Hamilton syringe with a 33 gauge needle and a microsyringe pump controller (Micro4, World Precision Instruments) at
ONLINE METHODS
Materials. AAV serotype 1 viral vectors were obtained commercially from the Penn Vector Core. All animal work was licensed under the UK Animals (Scientific Procedures) Act of 1986 with local ethical approval (MRC AWERB, Cambridge University). At least two mice were used for every condition tested, mice were not excluded, no randomization or blinding was used.
Chemical synthesis. All solvents and chemical reagents were purchased from Sigma-Aldrich or Fisher Scientific, and used without any further purification. The synthesis of Ne-(tert-butyloxycarbonyl)-l-lysine, "AlkK", (amino acid 1) was previously reported 6 . The synthesis of Azide diazobenzene biotin, "ADB", (compound 2) was as reported 17 .
Proteomic incorporation of AlkK via SORT into E. coli proteome. Chemically competent E. coli DH10B cells (50 µL) were doubly transformed with pBAD_ wtT4L_MbPylT-AGA plasmid 6 (2 µL, necessary for expression of PyltRNA-AGA) and pBK-MbPylS plasmid 6 (2 µL necessary for expression of PylRS). Transformed cells were recovered in 1 ml S.O.B. (supplemented with 0.2% glucose) for 1 h at 37 °C. 100 µL of the recovery was used to inoculate 50 ml LB-KT (50 µg/ml kanamycin and 25 µg/ml tetracycline) and the cultures incubated overnight (37 °C, 250 r.p.m.). Overnight cultures were diluted to OD 600 0.1 with LB-KT½ (as LB-KT, but with half the concentration of antibiotics) and divided into two 200 mL cultures. One culture was supplemented with AlkK (1 mM final concentration) and other with H 2 O (200 µL). Cultures were then incubated (37 °C, 250 r.p.m.) for 6 h. Cells were harvested by centrifugation (4,000 r.p.m., 4 °C, 20 min) and then washed two times by resuspending in 25 mL of ice cold PBS, and collecting by centrifugation (4,000 r.p.m., 4 °C, 20 min) between each wash. The final cell pellets were immediately frozen for storage.
Optimized SORT-M labeling of E. coli protein lysates. Frozen cell pellets were thawed and resuspended in 8 M urea (PBS, pH 7.8, 5 mL). Cells were lysed on ice using a microtip sonicator (amplitude 15, 11 min total sonication time, Soniprep 150 plus). Protein concentrations were determined by bicinchoninic acid (BCA) assay (Pierce). For a typical SORT-M experiment 100 µL of protein lysate (~10 mg/mL) was first reduced with 3 mM DTT (3 µL of 100 mM stock solution, 1 h at RT) and alkylated in 16.5 mM iodoacetamide (16.5 µL of 100 mM stock solution, 1 h at RT in dark). The lysates were then ligated with the addition of 100 µM Azide-AlexaFluor647 dye (2 µL of 5 mM stock solution in DMSO, ThermoFisher), 5 mM aminoguanidine (5 µL of 100 mM stock solution) and freshly made 50× "click mix" (2 µL of 50 mM CuSO 4 , 50 mM TBTA (Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) and 100 mM sodium ascorbate made in 1:1 DMSO:H 2 O, final concentration of Cu, TBTA, and ascorbate in reaction should be 1, 1, and 2 mM respectively). The samples were then incubated at room temperature for 4 h or overnight with end-over-end rotation (Hula mixer). Reactions were quenched with the addition of 1 mM AlkK 1. 2 µL aliquots (20 mg of protein) were used for 4-12% Bis-Tris SDS-Page gels and imaged on a Typhoon gel imager (excitation 633 nm/emission 670 nm). The gels were then stained with Coomassie stain (Expedeon) and imaged on a BioRad Gel Doc XR System. Plasmid construction. First, the hU6-PylT CAU gene was cloned by standard molecular biology protocols in a divergent orientation at the XbaI site upstream of the human Synapsin 1 promoter in pAAV-hSyn1-hChR2(H134R)-EYFP (Addgene #26973). Into this backbone, the mCherry::P2A::MmPylS coding sequence was cloned between the BamHI and EcoRI sites. The GFAP mCherry-P2A-MmPylS/PylT CAU was cloned by promoter replacement, the GFAP promoter refers to the GfaABC1D promoter throughout. The hSyn1 FLEX mCherry-P2A-MmPylS/PylT CAU (hSyn1-FLEX-SORT CAU ) was constructed by transferring loxP and lox2272 sites from pAAV-hSyn-DIO-HA-hM3D(Gq)-IRES-mCitrine (a gift from Bryan Roth, Addgene plasmid #50454) into the hSyn1-SORT CAU plasmid via 4-piece Gibson assembly.
Primary culture of dissociated rat cortical neurons and glial cells.
Dissociated rat cortical neurons (RCNs) were prepared as reported previously 8 . Brains of E17 fetuses from time-mated rats were dissected, trypsinized in the presence of 1% (wt/vol) DNase I (HT Biotechnology) and triturated with a 1 ml Gilson pipette. Dissociated cells were seeded at density of 20,000-50,000 cells/ cm 2 onto poly-l-lysine-coated coverslips or poly-l-lysine-coated polystyrene plates. The cells were cultured in Neurobasal media supplemented with B27 r.p.m., 5 s pulse). This washing process was repeated five times. An aliquot of the final wash was kept for analysis by SDS-PAGE. Specifically bound proteins were then eluted by resuspending the beads in 1% SDS in PBS supplemented with 50 mM Na 2 S 2 O 4 (100 µL) and incubating at room temperature for 30 min with end-over-end rotation (Hula mixer). The supernatant was collected by centrifugation (1,000 r.p.m., 5 s pulse). The elution was repeated two more times (50 µL), and the fractions pooled. 10% of the elutant was used for analysis by SDS-PAGE.
SORT-E from the striatal tissue of live mice. Striatal tissue from five brains (bilaterally injected, n = 3) was pooled and lysed in 1.5 mL of 8 M urea (PBS, pH 7.8) and homogenized with a disposable pestle. The tissue homogenates were sonicated in a water bath and subsequently cleared by centrifugation. Protein concentrations were determined by BCA assay (Pierce), and 1.3 mL of mouse striatal protein lysate (~8 mg/mL) was reduced with 3 mM DTT (1 h at RT) and alkylated in 16.5 mM iodoacetamide (30 min at RT in dark). The lysates were then supplemented with 100 µM azide-diazobenzene-biotin 2, 5 mM aminoguanidine and "click mix" (1 mM CuSO 4 , 1 mM TBTA (Tris[(1-benzyl-1H-1,2,3 -triazol-4-yl)methyl]amine) and 2 mM sodium ascorbate (final concentrations), made as 50× mix in 1:1 DMSO:H 2 O). The samples were then incubated at room temperature for 4 h with end-over-end rotation (Hula mixer). Reactions were quenched with the addition of 1 mM AlkK 1. 10 µL aliquots were taken at this stage as the input sample for subsequent SDS-PAGE analysis. The samples were precipitated by the addition of ten volumes of ice-cold methanol and incubated at -20 °C overnight. Precipitated protein was collected by centrifugation (3,200 rcf) , and the supernatant decanted. The protein pellet was washed with ice-cold methanol (5 mL), collected by centrifugation (3,200 rcf), and redissolved in urea buffer (1.5 mL, 8 M urea, PBS, pH 7.8). 50 µL of settled high-capacity streptavidin bead resin (Thermo Scientific) were added to the redissolved proteins and incubated with end-over-end rotation (Hula mixer) for 1.5 h, then collected by filtration through a spin column (Mini Bio-spin chromatography column Bio-Rad 731-1550). Unbound proteins were washed away by suspending beads in 1% SDS in PBS (500 µL) with 2 min end-over-end rotation (Hula mixer), and then collecting the beads by a short centrifugation (1,000 r.p.m., 5 s pulse). This washing process was repeated 15 times. An aliquot of the final wash was kept for analysis by SDS-PAGE. Specifically bound proteins were then eluted by resuspending the beads in 1% SDS in PBS supplemented with 50 mM Na 2 S 2 O 4 (50 µL) and incubating at room temperature for 30 min with end-over-end rotation (Hula mixer). The supernatant was collected by centrifugation (1,000 r.p.m., 5 s pulse). The elution was repeated three times, and the fractions pooled. 10% of the elutant was used for analysis by SDS-PAGE. The remaining elutant was concentrated to ~30 µL using a centrifugal filter unit (3,000 kDa cut-off amicon), and loaded into a 10% SDS-PAGE gel (15-min run) before each lane was cut into two bands for LC-MS/ MS analysis.
LC-MS/MS analysis (striatal SORT-E).
Each gel slice was subjected to in-gel tryptic digestion using a DigestPro automated digestion unit (Intavis Ltd.) to minimize manual handling. The resulting peptides were fractionated using an Ultimate 3000 nanoHPLC system in line with an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). In brief, peptides in 1% (vol/vol) formic acid were injected onto an Acclaim PepMap C18 nano-trap column (Thermo Scientific). After washing with 0.5% (vol/vol) acetonitrile 0.1% (vol/vol) formic acid, peptides were resolved on a 250 mm × 75 mm Acclaim PepMap C18 reversed phase analytical column (Thermo Scientific) over a 150-min organic gradient, using seven gradient segments (1-6% solvent B over 1 min, 6-15% B over 58 min, 15-32% B over 58 min, 32-40% B over 5 min, 40-90% B over 1 min, held at 90% B for 6 min and then reduced to 1% B over 1 min) with a flow rate of 300 nl min -1 . Solvent A was 0.1% formic acid and Solvent B was aqueous 80% acetonitrile in 0.1% formic acid. Peptides were ionized by nano-electrospray ionization at 2.2 kV using a stainless steel emitter with an internal diameter of 30 mm (Thermo Scientific) and a capillary temperature of 250 °C.
All spectra were acquired using an Orbitrap Fusion Tribrid mass spectrometer controlled by Xcalibur 2.0 software (Thermo Scientific) and operated in datadependent acquisition mode. FTMS1 spectra were collected at a resolution of 120,000 over a scan range (m/z) of 350-1,550, with an automatic gain control target of 400,000 and a max injection time of 100 ms. Precursors were filtered with an intensity range from 5E3 to 1E20, according to charge state (to include charge states 2-7) and with monoisotopic precursor selection. The Data Dependent mode was set to TopSpeed and the most intense ions were selected for MS/MS. flow rate of 0.5 ml/min. The needle was left in place at the injection site for 2 min before being slowly withdrawn. Two weeks after the surgery, the mice received AlkK 1, administered orally in the drinking water (15% black currant-flavored water containing 30 mg/mL AlkK 1) or control drink with no AlkK 1 for one additional week. After the 7 d of AlkK treatment, the mice were euthanized, and the brains were either post-fixed in 4% paraformaldehyde and preserved in 30% sucrose for sectioning or dissected to remove the striatum or hippocampus, which was frozen on dry-ice for further analyses. To assess the effect of the different components of the SORT labeling system, we injected mice with hSyn1-SORT AVV and fed them AlkK for a week ("SORT-E") while in parallel creating three control groups: mice only injected with AAV ("AAV"), fed only AlkK ("AlkK") or neither AAV or AlkK ("Control"). The striatal tissues from all four groups were lysed in 8 M urea and separated on SDS-PAGE before subjecting the gel slices to liquid chromatography (LC)-MS/MS.
Immunofluorescence microscopy and confocal imaging of brain sections.
Fixed and cryopreserved brains (unilaterally injected) were cut into 40 µm coronal sections on a freezing microtome. For observation of mCherry fluorescence (PylS expression) throughout the brain, coronal sections from anterior to posterior were mounted with hardset VECTASHIELD H-1500 with DAPI (Vectorlabs) and images were acquired with a 4× objective on a Nikon Eclipse TE2000 microscope and processed in ImageJ (NIH). Immunostaining for co-localization was performed by overnight incubation with monoclonal rabbit anti-NeuN (Abcam, AB177487; 1:250) and polyclonal chicken anti-GFAP (MerckMillipore, AB5541; 1:500) and mounted with VECTASHIELD H-1500 with DAPI (Vectorlabs). Confocal images were acquired on a Zeiss LSM 710 confocal microscope and processed in ImageJ (NIH).
Fluorescent labeling of protein lysates. Cell, SCN, and brain lysates (striatal and hippocampal) were first reduced in 3 mM DTT (1 h at RT) and then alkylated in 16.5 mM iodoacetamide (30 min at RT in dark). For SORT-M using AlkK, the lysates were then supplemented with 100 µM Azide-AlexaFluor647 (ThermoFisher), 5 mM aminoguanidine, and "click mix" (1 mM CuSO 4 , 1 mM TBTA (Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) and 2 mM sodium ascorbate (final concentrations), made as 50× mix in 1:1 DMSO:H 2 O). The samples were then incubated at room temperature for 4 h or overnight. All labeled samples were separated on 4-12% Bis-Tris SDS-Page gels and imaged on a Typhoon gel imager (excitation 633 nm/emission 670 nm). The gels were then stained with Coomassie stain (Expedeon) and imaged on a BioRad Gel Doc XR System. Optimized SORT-E for E. coli lysate. Frozen cell pellets were thawed and resuspended in 8 M urea (PBS, pH 7.8, 5 mL). Cells were lysed on ice using a microtip sonicator (amplitude 15, 11 m total sonication time, Soniprep 150 plus). Protein concentrations were determined by BCA assay (Pierce). For a typical SORT-E experiment 4 mL of protein lysate (~10 mg/mL) was first reduced with 3 mM DTT (24 µL of 500 mM stock solution, 1 h at RT) and alkylated in 16.5 mM iodoacetamide (66 µL of 1 M stock solution, 1 h at RT in dark). The lysates were then ligated with the addition of 100 µM azide-diazobenzene-biotin 2 (8 µL of 5 mM stock solution in DMSO), 5 mM aminoguanidine (20 µL of 1 M stock solution) and freshly made 50× "click mix" (80 µL of 50 mM CuSO 4 , 50 mM TBTA (Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) and 100 mM sodium ascorbate made in 1:1 DMSO:H 2 O, final concentration of Cu, TBTA, and ascorbate in reaction should be 1, 1, and 2 mM respectively). The samples were then incubated at room temperature overnight with end-over-end rotation (Hula mixer). Reactions were quenched with the addition of 1 mM AlkK 1. 10 µL aliquots were taken at this stage as the input sample for subsequent SDS-PAGE analysis. The samples were precipitated by the addition of ten volumes of ice-cold methanol and incubated at -20 °C overnight. Precipitated protein was collected by centrifugation (3,200 rcf) , and the supernatant decanted. The protein pellets were washed with ice-cold methanol (2 × 25 mL), collected by centrifugation (3200 rcf), and redissolved in urea buffer (5 mL, 8 M urea, PBS, pH 7.8). 100 µL of high-capacity streptavidin beads slurry (Thermo Scientific) were added to the redissolved proteins and incubated with end-over-end rotation (Hula mixer) for 1.5 h, then collected by filtration through a spin column (Mini Bio-spin chromatography column Bio-Rad 731-1550). Unbound proteins were washed away by suspending beads in 1% SDS in PBS (500 µL) with 2 min end-over-end rotation (Hula mixer); the beads were then collected by a short centrifugation (1,000 the proteins only identified in SORT-E output, but not in the control output (Supplementary Data 1) .
The SORT-E ID proteome (1,789 proteins) and the SORT-E NS (608 proteins) were submitted to DAVID bioinformatics 24 with a background proteome of 3,787 proteins (Supplementary Data 1) defined as proteins identified by LC-MS/MS across all our samples, including gel band fractionated (three bands) load of 15 µg total striatum protein lysate. From the GO:Cellular Compartment (CC_FAT) the Benjamini-Hockberg P-values for GO:0097458 "Neuron Part" were reported for SORT-E ID and SORT-E NS. Figure 2m : log 2 (LFQ SORT-E Output /LFQ Total Striatum ), LFQ is the label-free quantification value from LC-MS/ MS analysis. The depletion of glial markers (Oligodendrocyte markers: Plp1, Mog, Mag, Cnp, Mbp,, Enpp6, Bcas1; Astrocytes markers: Slc1a2, Scl1a3, GFAP, Aldh1l1, Vim, Glul, S100b) was calculated and plotted as Log 2 mean values with standard error of mean, n = 3 independent experiments. Statistics were calculated with a one-sample t-test (H 0 :µ = 0) and the significance of the two-tailed test were reported as *P-value < 0.05 and ** P-value < 0.005. P values were Plp1 Figure 2n: proteins that are more than tenfold upregulated in cultured glia with respect to neurons in Sharma et al. 3 and are present in the SORT-E output were mapped onto proteins that are "SORT-E De-enriched " (LFQ SORT-E Output /LFQ Total Striatum < 1), and proteins that are "SORT-E Enriched" (LFQ SORT-E Output /LFQ Total Striatum > 1). The Euler diagram indicates the number of proteins found in each category. Hypergeometric distribution probability analyses 25 were then used to calculate a P value for the significance of the proteins from cultured glia in "SORT-E De-enriched" and for the significance of the proteins from cultured glia in "SORT-E Enriched. " Figure  2o: proteins that are more than tenfold upregulated in acutely isolated glia with respect to neurons in Sharma et al. 3 and are present in the SORT-E output were mapped and analyzed as described in n. Additional information can be found in the Life Sciences Reporting Summary that accompanies this manuscript.
Data availability statement. The data sets generated or analyzed during the current study are available from the corresponding author upon reasonable request. The mass spectrometry data generated in this study have been deposited in the PRIDE database with accession number PXD008380. AAV vectors are available from the corresponding author upon reasonable request. Precursors were filtered according to charge state (to include charge states 2-7) and with monoisotopic precursor selection. Previously interrogated precursors were excluded using a dynamic window (40 s ± 10 p.p.m.). The MS2 precursors were isolated with a quadrupole mass filter set to a width of 1.6 m/z. ITMS2 spectra were collected with an AGC target of 5,000, max injection time of 50 ms and HCD collision energy of 35%.
MS data analysis. MS raw files were processed using the MaxQuant software 21 (version 1.5.0.0) and searched with the embedded Andromeda search engine 22 against the reviewed mouse sequence database (Uniprot). Cysteine carbamidomethylation was set as a fixed modification and N-acetylation of protein and oxidation of methionine as variable modifications. Peptides with a minimum of seven amino acids were considered and the required FDR was set to 1% at peptide and protein levels. The maximum allowed missed cleavages was set to two. Protein quantification was done by label-free quantification (Fast LFQ) with default settings.
Downstream processing of mass spectrometry data was done with Perseus 23 from the MaxQuant ProteinGroups output file, contaminations and reverse hits were removed by filtering. The remaining protein quantifications were log 2 transformed.
Statistics and reproducibility. Figure 1b , the experiment was repeated 2 times, using independent cultures with similar results. Figure 1c , the experiment was repeated 2 times, using independent slices, with similar results. Figure 1d , the experiment was repeated 3 times, using independent slices, with similar results. Figure 1e , the experiment was repeated 2 times, using independent slices, with similar results. Figure 2a , the injection was repeated 3 independent times with similar results. Figure 2b , the immunofluorescence and fluorescence was repeated on 3 sections from two independent mice with similar results. Figure  2c , the gel and imaging was repeated 2 independent times with similar results. Figure 2d , the gel and imaging was repeated 2 independent times with similar results. Figure 2e , the injection was repeated 3 independent times with similar results. Figure 2f , the immunofluorescence and fluorescence was repeated on 3 sections with similar results. Figure 2g , the gel and imaging was repeated 2 independent times with similar results. Figure 2h , the injection was repeated 3 independent times with similar results. Figure 2i , the immunofluorescence and fluorescence was repeated on 3 sections with similar results. Figure 2j , the gel and imaging was repeated 2 independent times with similar results. Figure  2k , each lane represents an independent SORT-E experiment derived from n = 5 mice. Figure 2l , Each Log 2 (SORT-E output/control output) data point is calculated in Perseus using n = 3 SORT-E output measurements and n = 6 Control output measurements. The SORT-E IDs were defined from the Log 2 (SORT-E output/control output) with a significance curve S 0 = 1, FDR < 0.05, plus 1 nature research | life sciences reporting summary Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes were chosen such that the total yield of protein following SORT was sufficient to yield a large number of identifications and based on the variation observed in pilot experiments.
Data exclusions
Describe any data exclusions. No data exclusions
Replication
Describe whether the experimental findings were reliably reproduced.
Replicates were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Mice were allocated to the SORT group or the control group at random. Following this allocation samples were processed in parallel.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The key data acquisition and analysis steps were automated so blinding was not relevant.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
